Published in Int J Radiat Oncol Biol Phys on October 30, 2009
Proton beam therapy and localised prostate cancer: current status and controversies. Br J Cancer (2013) 1.08
Particle therapy using carbon ions or protons as a definitive therapy for patients with primary sacral chordoma. Br J Radiol (2013) 0.93
Current knowledge and future research directions in treatment-related second primary malignancies. EJC Suppl (2014) 0.85
Second primary cancers after radiation for prostate cancer: a review of data from planning studies. Radiat Oncol (2013) 0.85
Risk of secondary cancers from scattered radiation during intensity-modulated radiotherapies for hepatocellular carcinoma. Radiat Oncol (2014) 0.82
Technical advances and pitfalls in head and neck radiotherapy. J Oncol (2012) 0.80
Risk of second cancer from scattered radiation of intensity-modulated radiotherapies with lung cancer. Radiat Oncol (2013) 0.78
Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression. Acta Oncol (2013) 0.77
Dosimetric effects of sectional adjustments of collimator angles on volumetric modulated arc therapy for irregularly-shaped targets. PLoS One (2017) 0.75
Secondary Malignancy Risk Following Proton Radiation Therapy. Front Oncol (2015) 0.75
Mutations of the human interferon alpha-2b (hIFNα-2b) gene in cancer patients receiving radiotherapy. Am J Cancer Res (2015) 0.75
Dosimetric evaluation of a simple planning method for improving intensity-modulated radiotherapy for stage III lung cancer. Sci Rep (2016) 0.75
Proton therapy for early stage prostate cancer: is there a case? Onco Targets Ther (2016) 0.75
A treatment planning study of proton arc therapy for para-aortic lymph node tumors: dosimetric evaluation of conventional proton therapy, proton arc therapy, and intensity modulated radiotherapy. Radiat Oncol (2016) 0.75
Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy. Int J Radiat Oncol Biol Phys (2010) 1.88
Simulation and prediction of the adaptive immune response to influenza A virus infection. J Virol (2009) 1.76
Circulating α-klotho levels in CKD and relationship to progression. Am J Kidney Dis (2013) 1.76
A new homogeneity index based on statistical analysis of the dose-volume histogram. J Appl Clin Med Phys (2007) 1.68
Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Radiology (2005) 1.57
Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy. J Clin Oncol (2009) 1.56
Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer. Breast Cancer Res Treat (2010) 1.30
Controlling the lattice parameters of gold nanoparticle FCC crystals with duplex DNA linkers. Nano Lett (2008) 1.30
Blockade of the Wnt/β-catenin pathway attenuates bleomycin-induced pulmonary fibrosis. Tohoku J Exp Med (2011) 1.20
Dosimetric comparison of four different external beam partial breast irradiation techniques: three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy. Radiother Oncol (2008) 1.18
Modeling and estimation of kinetic parameters and replicative fitness of HIV-1 from flow-cytometry-based growth competition experiments. Bull Math Biol (2008) 1.17
Mature cataract and lens-induced glaucoma associated with an asymptomatic intralenticular foreign body. J Cataract Refract Surg (2007) 1.16
Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy. Int J Radiat Oncol Biol Phys (2007) 1.14
DNA-controlled assembly of a NaTl lattice structure from gold nanoparticles and protein nanoparticles. Nat Mater (2010) 1.11
3D CT-based high-dose-rate brachytherapy for cervical cancer: clinical impact on late rectal bleeding and local control. Radiother Oncol (2010) 1.10
Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesis. Hepatology (2008) 1.08
Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy. PLoS One (2012) 1.08
Single-dose versus fractionated stereotactic radiotherapy for brain metastases. Int J Radiat Oncol Biol Phys (2010) 1.08
Craniospinal irradiation techniques: a dosimetric comparison of proton beams with standard and advanced photon radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.05
Locoregional recurrence of breast cancer in patients treated with breast conservation surgery and radiotherapy following neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys (2010) 1.05
A novel protein phosphatase indirectly regulates phytochrome-interacting factor 3 via phytochrome. Biochem J (2008) 1.05
A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer. Breast Cancer Res Treat (2007) 1.04
Role of the plastidic glucose translocator in the export of starch degradation products from the chloroplasts in Arabidopsis thaliana. New Phytol (2010) 1.02
Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients. Breast Cancer Res Treat (2006) 1.02
CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters. Int J Radiat Oncol Biol Phys (2005) 1.02
Inter- and intrafractional movement-induced dose reduction of prostate target volume in proton beam treatment. Int J Radiat Oncol Biol Phys (2008) 1.01
Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys (2005) 1.00
Secondary neutron doses for several beam configurations for proton therapy. Int J Radiat Oncol Biol Phys (2009) 0.99
Benign pulmonary metastasizing leiomvomatosis: case report and a review of the literature. Korean J Intern Med (2006) 0.99
Prognostic Impact of [18F] FDG-PET in operable breast cancer treated with neoadjuvant chemotherapy. Ann Surg Oncol (2009) 0.99
Visceral fat thickness is associated with carotid atherosclerosis in peritoneal dialysis patients. Obesity (Silver Spring) (2011) 0.98
NAT2, CYP2C9, CYP2C19, and CYP2E1 genetic polymorphisms in anti-TB drug-induced maculopapular eruption. Eur J Clin Pharmacol (2010) 0.96
Intensity-modulated radiotherapy with a belly board for rectal cancer. Int J Colorectal Dis (2006) 0.96
High prevalence of bronchiectasis in adults: analysis of CT findings in a health screening program. Tohoku J Exp Med (2010) 0.95
Genes expressed in the latex of Hevea brasiliensis. Tree Physiol (2000) 0.95
Transforming growth factor-β adaptor, β2-spectrin, modulates cyclin dependent kinase 4 to reduce development of hepatocellular cancer. Hepatology (2011) 0.95
Progression of aortic arch calcification over 1 year is an independent predictor of mortality in incident peritoneal dialysis patients. PLoS One (2012) 0.95
Sugar-hormone cross-talk in anthocyanin biosynthesis. Mol Cells (2012) 0.93
Human papillomavirus in oropharyngeal squamous cell carcinomas in Korea: use of G1 cycle markers as new prognosticators. Head Neck (2011) 0.91
Development of array-type prompt gamma measurement system for in vivo range verification in proton therapy. Med Phys (2012) 0.91
Transscleral fixation by injector implantation of a foldable intraocular lens. Ophthalmic Surg Lasers Imaging (2010) 0.91
Comparison between in vivo dosimetry and barium contrast technique for prediction of rectal complications in high-dose-rate intracavitary radiotherapy in cervix cancer patients. Strahlenther Onkol (2003) 0.91
Early initiation of continuous renal replacement therapy improves patient survival in severe progressive septic acute kidney injury. J Crit Care (2012) 0.90
Pretreatment carbohydrate antigen 19-9 level indicates tumor response, early distant metastasis, overall survival, and therapeutic selection in localized and unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys (2011) 0.90
GSTT1 and GSTM1 null mutations and adverse reactions induced by antituberculosis drugs in Koreans. Tuberculosis (Edinb) (2009) 0.90
Characteristics of movement-induced dose reduction in target volume: a comparison between photon and proton beam treatment. Med Dosim (2008) 0.89
Urine output is associated with prognosis in patients with acute kidney injury requiring continuous renal replacement therapy. J Crit Care (2013) 0.89
Outcomes of positron emission tomography-staged clinical N3 breast cancer treated with neoadjuvant chemotherapy, surgery, and radiotherapy. Int J Radiat Oncol Biol Phys (2011) 0.89
Phase II trial of proton beam accelerated partial breast irradiation in breast cancer. Radiother Oncol (2013) 0.89
Good glycemic control is associated with better survival in diabetic patients on peritoneal dialysis: a prospective observational study. PLoS One (2012) 0.89
Clinical outcomes, when matched at presentation, do not vary between adult-onset Henöch-Schönlein purpura nephritis and IgA nephropathy. Kidney Int (2012) 0.88
Availability of tongue diagnosis system for assessing tongue coating thickness in patients with functional dyspepsia. Evid Based Complement Alternat Med (2013) 0.88
Radiosensitivity enhancement by combined treatment of celecoxib and gefitinib on human lung cancer cells. Clin Cancer Res (2006) 0.87
Comparison of the belly board device method and the distended bladder method for reducing irradiated small bowel volumes in preoperative radiotherapy of rectal cancer patients. Int J Radiat Oncol Biol Phys (2005) 0.87
Accumulation of p53 determined by immunohistochemistry as a prognostic marker in node negative breast cancer; analysis according to St Gallen consensus and intrinsic subtypes. J Surg Oncol (2010) 0.87
Evaluation of parotid gland function following intensity modulated radiation therapy for head and neck cancer. Cancer Res Treat (2006) 0.87
Radical prostatectomy versus external beam radiotherapy for localized prostate cancer: Comparison of treatment outcomes. Strahlenther Onkol (2014) 0.87
Protective effects of hominis placenta hydrolysates on radiation enteropathy in mice. Nat Prod Res (2011) 0.87
Secondary radiation doses of intensity-modulated radiotherapy and proton beam therapy in patients with lung and liver cancer. Radiother Oncol (2011) 0.86
Primary systemic therapy with intermittent weekly paclitaxel plus gemcitabine in patients with stage II and III breast cancer: a phase II trial. Invest New Drugs (2009) 0.86
Phase 2 trial of accelerated, hypofractionated whole-breast irradiation of 39 Gy in 13 fractions followed by a tumor bed boost sequentially delivering 9 Gy in 3 fractions in early-stage breast cancer. Int J Radiat Oncol Biol Phys (2013) 0.86
Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer (EORTC) Breast-Cancer-Specific Quality of Life Questionnaire (EORTC QLQ-BR23). Support Care Cancer (2004) 0.86